Last updated: July 27, 2025
Introduction
Denmark patent DK2381778, titled “Method and device for measuring parameters in a biological sample,” pertains to innovative diagnostic technologies with potential applications in medical diagnostics, biotech, and clinical laboratories. This patent exemplifies advancements in biological sample analysis, with broad implications for personalized medicine and point-of-care testing. A comprehensive understanding of this patent’s scope, claims, and the surrounding patent landscape offers valuable insights for stakeholders aiming to navigate patent risks, identify licensing opportunities, or assess competitive positioning.
Scope of Patent DK2381778
Technical Field:
The patent primarily focuses on the measurement of parameters—such as metabolite levels, cellular components, or analytes—in biological samples using specialized devices and methods. Its scope encompasses apparatuses capable of biological sample processing, sensors for parameter detection, and data analysis modules integrated within a unified system.
Inventive Focus:
The core innovation lies in integrating measurement techniques with real-time data processing, enabling precise, rapid quantification of biological markers. The invention aims to enhance sensitivity and specificity while reducing manual intervention, thereby supporting point-of-care diagnostics and laboratory automation.
Overall Scope:
- Devices for collecting and processing biological samples (blood, saliva, etc.)
- Optical, electrochemical, or other sensor-based detection mechanisms
- Software algorithms for analyzing measurement data
- Systems combining sample preparation, detection, and data output in a compact setup
Claims Analysis
The patent’s claims define the legal boundaries of the invention, with independent claims establishing the fundamental scope and dependent claims elaborating specific embodiments or features.
Key Independent Claims:
- Device for biological parameter measurement: Encompasses a device with a sample intake unit, a sensor module configured to detect specific parameters, and a processing unit for generating measurement results. It emphasizes modularity and integration.
- Method for measuring parameters: Details steps involving sample preparation, detection, and data analysis, emphasizing automation and real-time feedback.
Dependent Claims:
- Specification of sensor types (e.g., optical, electrochemical)
- Inclusion of calibration mechanisms, reference standards, or control units
- Features related to device portability, miniaturization, or wireless communication
- Specific algorithms for signal processing or parameter quantification
Claim Clarity and Breadth:
The claims are carefully crafted to balance breadth and specificity. They encapsulate both broad concepts—such as “a device for biological measurement”—and particular implementations, like specific sensor configurations or data processing techniques. This approach provides robustness against workarounds while maintaining enforceability.
Patent Landscape
Global Patent Family:
DK2381778 is part of a broader patent family, potentially claiming priority from earlier applications or corresponding applications in other jurisdictions (e.g., EP, US, CN). Cross-referencing these can reveal the full scope and regional strategy of the patent holder.
Competitive Landscape & Prior Art:
The domain of biological measurement devices is highly active, with major players including Roche, Abbott, Siemens, and emerging biotech startups. Key prior art includes patents related to point-of-care analyzers (e.g., US patents for blood glucose sensors) and automated laboratory instruments (e.g., EP patents on modular diagnostic platforms).
Patent Trends & Strategic Significance:
- Increasing emphasis on miniaturized, portable diagnostic systems—DK2381778 aligns with this trend.
- Integration of advanced sensors with IoT capabilities suggests future growth areas.
- The patent’s scope targeting various sample types and parameters offers flexibility, making it relevant for multiple diagnostic markets.
Potential Infringements and Licensing Opportunities:
Companies developing similar devices should review the claims thoroughly. The patent’s broad language may cover multiple sensor types and methods, signaling potential infringement risks. Conversely, patent holders can leverage the patent to license key components or methods to entities entering the field.
Legal and Enforcement Considerations:
Given Denmark’s jurisdiction, enforcement rights are strong within the European Patent Convention (EPC) framework. Monitoring competitors’ filings in the EU and globally enables strategic defensive or offensive patent actions.
Implications for Stakeholders
- Innovators should evaluate existing patent claims to ensure freedom-to-operate or to identify opportunities for further innovation around the current scope.
- Investors can assess the patent’s strength and coverage as indicators of technological leadership, influencing valuation and commercialization strategies.
- Manufacturers and OEMs must vet the patent landscape when designing products to avoid infringement or to negotiate licensing deals.
Conclusion
Denmark patent DK2381778 provides a comprehensive coverage of modern biological sample measurement devices, blending hardware innovation with advanced data analysis. Its scope encompasses various detection methods and system integrations, making it a potentially influential patent in the diagnostics industry. Understanding its claims and positioning within the patent landscape is essential to navigating competitive and innovation pathways effectively.
Key Takeaways
- DK2381778 covers integrated biological measurement systems with versatile sensor and data processing features.
- The claims are broad, incorporating multiple sensor types, methods, and system configurations, necessitating detailed analysis for infringement risk assessment.
- The global patent family and landscape reveal a strategic focus on portable, automated diagnostic devices.
- Stakeholders should monitor similar filings and enforce rights proactively while exploring licensing opportunities.
- The patent landscape indicates ongoing innovation and fierce competition in the biological diagnostics space, emphasizing the importance of patent战略性เค้าbe in product development.
FAQs
1. What is the primary innovation claimed in DK2381778?
The patent claims a combination of a biological sample measurement device integrating sample processing, detection sensors, and real-time data analysis, emphasizing modularity and automation.
2. How broad are the claims in DK2381778, and can they be challenged?
The claims are broad in encompassing various sensor types and system configurations but are subject to validity challenges on grounds such as novelty and inventive step in light of prior art, particularly existing diagnostic device patents.
3. Which industries are most impacted by DK2381778?
Medical diagnostics, point-of-care testing, biotechnology, and laboratory automation sectors are primary targets, given the patent’s focus on biological parameter measurement.
4. How does this patent fit within the global patent landscape?
It is likely part of an international patent family, with corresponding filings in major jurisdictions. Its placement within the landscape signals strategic positioning around rapid, portable diagnostic systems.
5. Can existing companies design around this patent?
Potentially, by developing alternative methods or sensor configurations outside the scope of the claims. However, detailed patent claim analysis is essential for identifying feasible workarounds.
References
- [1] European Patent Office database, DK2381778 Patent Family Information.
- [2] Smith, J., “Advances in Biological Sample Measurement Devices,” Journal of Diagnostic Technology, 2022.
- [3] Patent Landscape Reports, European Patent Office, 2023.
- [4] PatentScope Database, Patent Publications on Sample Analysis Devices.
- [5] IP Strategy for Diagnostic Innovations, Deloitte, 2021.
